Literature DB >> 29435793

Reply to the letter to the editor regarding: A prospective randomized trial evaluating the outcomes of transanal hemorrhoidal dearterialization versus tissue-selecting technique.

L H Leung1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29435793     DOI： 10.1007/s10151-018-1752-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  6 in total

1.  A prospective randomized trial on transanal hemorrhoidal dearterialization versus stapler hemorrhoidectomy: methodological issues that need to be clarified.

Authors:  S Biondo; L Trenti; E Kreisler; C Ratto
Journal:  Tech Coloproctol       Date:  2017-10-28       Impact factor: 3.781

2.  Short-term outcomes of transanal haemorrhoidal dearterialization versus tissue-selecting technique.

Authors:  Y Bashir; Q Ulain; E Eguare
Journal:  Tech Coloproctol       Date:  2018-01-16       Impact factor: 3.781

Review 3.  Comparison of transanal haemorrhoidal dearterialisation and stapled haemorrhoidopexy in management of haemorrhoidal disease: a retrospective study and literature review.

Authors:  Y P Tsang; K L B Fok; Y S H Cheung; K W M Li; C N Tang
Journal:  Tech Coloproctol       Date:  2014-06-07       Impact factor: 3.781

4.  Treatment of grade III and IV haemorrhoidal disease with PPH or THD. A randomized trial on postoperative complications and short-term results.

Authors:  Sebastiaan Festen; M J van Hoogstraten; A A W van Geloven; M F Gerhards
Journal:  Int J Colorectal Dis       Date:  2009-12       Impact factor: 2.571

5.  Prospective evaluation of stapled haemorrhoidopexy versus transanal haemorrhoidal dearterialisation for stage II and III haemorrhoids: three-year outcomes.

Authors:  P Giordano; P Nastro; A Davies; G Gravante
Journal:  Tech Coloproctol       Date:  2011-02-12       Impact factor: 3.781

6.  Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial.

Authors:  Steven R Brown; James P Tiernan; Angus J M Watson; Katie Biggs; Neil Shephard; Allan J Wailoo; Mike Bradburn; Abualbishr Alshreef; Daniel Hind
Journal:  Lancet       Date:  2016-05-25       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.